The earnings power and performance of AMP's (ASX:AMP) China associates in fiscal year 2025 appeared to have been "overlooked" as investors focused on sharp misses in the Australian business, driving the share price 26% lower, Jarden said in a Thursday note.

These associates contribute over 30% of the company's group net profit after tax and are growing at 36% per year, the investment and advisory firm said.

Jarden suggests that AMP hold on to its Chinese stakes, improve disclosure, and inform the market about the asset management characteristics that warrant higher valuations compared with the insurance conglomerate comparables the market is applying, according to the note.

Jarden maintained its overweight rating on AMP and raised its price target to AU$1.75 from AU$1.65.